These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW. Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694 [Abstract] [Full Text] [Related]
3. Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care. Balla S, Ekpo EP, Wilemon KA, Knowles JW, Rodriguez F. Curr Atheroscler Rep; 2020 Aug 20; 22(10):60. PubMed ID: 32816232 [Abstract] [Full Text] [Related]
4. Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry. Vrablik M, Raslová K, Vohnout B, Blaha V, Satny M, Kyselak O, Vaclova M, Urbanek R, Maskova J, Soska V, Freiberger T. Atherosclerosis; 2018 Oct 20; 277():355-361. PubMed ID: 30270071 [Abstract] [Full Text] [Related]
5. Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome. Krasieva K, Gencer B, Locatelli I, Carballo D, Muller O, Fournier S, Matter CM, Räber L, Rodondi N, Mach F, Nanchen D. Circ Cardiovasc Qual Outcomes; 2024 Aug 20; 17(8):e010790. PubMed ID: 38899458 [Abstract] [Full Text] [Related]
6. The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia. Lalić K, Rajković N, Popović L, Lukač SS, Stošić L, Rasulić I, Lalić NM. Atherosclerosis; 2018 Oct 20; 277():298-303. PubMed ID: 30270062 [Abstract] [Full Text] [Related]
7. Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014). Bucholz EM, Rodday AM, Kolor K, Khoury MJ, de Ferranti SD. Circulation; 2018 May 22; 137(21):2218-2230. PubMed ID: 29581125 [Abstract] [Full Text] [Related]
8. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry. Duell PB, Gidding SS, Andersen RL, Knickelbine T, Anderson L, Gianos E, Shrader P, Kindt I, O'Brien EC, McCann D, Hemphill LC, Ahmed CD, Martin SS, Larry JA, Ahmad ZS, Kullo IJ, Underberg JA, Guyton J, Thompson P, Wilemon K, Roe MT, Rader DJ, Cuchel M, Linton MF, Shapiro MD, Moriarty PM, Knowles JW. Atherosclerosis; 2019 Oct 22; 289():85-93. PubMed ID: 31487564 [Abstract] [Full Text] [Related]
11. Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care. Iyen B, Akyea RK, Weng S, Kai J, Qureshi N. Open Heart; 2021 Oct 22; 8(2):. PubMed ID: 34702779 [Abstract] [Full Text] [Related]
19. Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry. de Ferranti SD, Shrader P, Linton MF, Knowles JW, Hudgins LC, Benuck I, Kindt I, O'Brien EC, Peterson AL, Ahmad ZS, Clauss S, Duell PB, Shapiro MD, Wilemon K, Gidding SS, Neal W. J Pediatr; 2021 Feb 01; 229():70-77. PubMed ID: 32976895 [Abstract] [Full Text] [Related]